Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-06 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
| 2022-02-15 | New | $9,281,159 | $9,281,159 | Equity Only | 06b | SEC link |
| 2020-01-10 | New | $10,000,013 | $10,000,013 | Equity Only | 06b | SEC link |
| 2018-07-27 | New | $8,999,991 | $8,999,991 | Equity Only | 06b | SEC link |
| 2017-03-15 | New | $5,499,998 | $5,499,998 | Equity Only | 06b | SEC link |
| 2016-03-15 | New | $2,150,002 | $2,150,002 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Gerrit Adams | Director |
| Olav B. Bergheim | Director, Executive |
| Daniel Forche | Director, Executive |
| William J. Link | Director |
| Derek Maetzold | Director |
| Hugh Neuharth | Director |
| Alejandro Sanchez | Director |
| Andrew Wade | Executive |